Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study

    Folate receptor 1 (FOLR1) is expressed in the majority of ovarian carcinomas (OvCa), making it an attractive target for therapy. However, clinical trials testing anti-FOLR1 therapies in OvCa show mixed results...

    M Köbel, J Madore, S J Ramus, B A Clarke, P D P Pharoah in British Journal of Cancer (2014)

  2. Article

    Erratum: Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer

    Correction to: Oncogenesis (2014) 3, e100; doi:10.1038/oncsis.2014.14; published online 21 April 2014 Since the publication of the above manuscript the authors have identified an error in the author list; the ...

    F Al-Ejeh, P T Simpson, J M Saunus, K Klein, M Kalimutho, W Shi, M Miranda in Oncogenesis (2014)

  3. Article

    Open Access

    Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer

    Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype lacking expression of estrogen and progesterone receptors (ER/PR) and HER2, thus limiting therapy options. We hypothesized that meta-...

    F Al-Ejeh, P T Simpson, J M Sanus, K Klein, M Kalimutho, W Shi, M Miranda in Oncogenesis (2014)

  4. Article

    Open Access

    FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium

    Breast cancer is one of the most common malignancies in women. Genome-wide association studies have identified FGFR2 as a breast cancer susceptibility gene. Common variation in other fibroblast growth factor (FGF...

    D Agarwal, S Pineda, K Michailidou, J Herranz, G Pita in British Journal of Cancer (2014)

  5. No Access

    Article

    Mutations in EGFR, BRAF and RAS are rare in triple-negative and basal-like breast cancers from Caucasian women

    Basal-like and triple-negative breast cancers usually display a high level of genomic instability and often carry TP53 mutations. Mutations in EGFR have been reported in about 10 % triple-negative tumours from Ch...

    E. Tilch, T. Seidens, S. Cocciardi, L. E. Reid in Breast Cancer Research and Treatment (2014)

  6. Article

    Open Access

    Estimating single nucleotide polymorphism associations using pedigree data: applications to breast cancer

    Pedigrees with multiple genotyped family members have been underutilised in breast cancer (BC) genetic-association studies. We developed a pedigree-based analytical framework to characterise single-nucleotide ...

    D R Barnes, D Barrowdale, J Beesley, X Chen, P A James in British Journal of Cancer (2013)

  7. Article

    Open Access

    Genome-wide association analysis of coffee drinking suggests association with CYP1A1/CYP1A2 and NRCAM

    Coffee consumption is a model for addictive behavior. We performed a meta-analysis of genome-wide association studies (GWASs) on coffee intake from 8 Caucasian cohorts (N=18 176) and sought replication of our top...

    N Amin, E Byrne, J Johnson, G Chenevix-Trench, S Walter, I M Nolte in Molecular Psychiatry (2012)

  8. Article

    Open Access

    Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study

    The variable penetrance of breast cancer in BRCA1/2 mutation carriers suggests that other genetic or environmental factors modify breast cancer risk. Two genes of special interest are prohibitin (PHB) and methyle...

    A Jakubowska, D Rozkrut, A Antoniou, U Hamann, R J Scott in British Journal of Cancer (2012)

  9. Article

    Open Access

    The use of the Illumina FFPE Restoration Protocol to obtain suitable quality DNA for SNP-based CGH– a pilot study

    AN Hosein, S Cocciardi, J Jayanthan, S Song in Hereditary Cancer in Clinical Practice (2012)

  10. Article

    Open Access

    A multi-center study to evaluate the impact of germline BRCA1 and BRCA2 mutations on ovarian cancer survival

    KL Bolton, G Chenevix-Trench, C Goh, S Sadetzki in Hereditary Cancer in Clinical Practice (2012)

  11. Article

    Open Access

    Searching for BRCA3 by exome sequencing

    I Makunin, M Stark, M Gartside, G Chenevix-Trench in Hereditary Cancer in Clinical Practice (2012)

  12. Article

    Open Access

    Primary treatment patterns in women recruited to the Australian Ovarian Cancer Study

    J Hung, S Fereday, P Harnett, D Giles, B Gao in Hereditary Cancer in Clinical Practice (2012)

  13. Article

    Open Access

    Common genomic variants associated with breast cancer predict the risk of second primary breast cancer diagnosis

    S Sawyer, J McKinley, G Mitchell in Hereditary Cancer in Clinical Practice (2012)

  14. Article

    Open Access

    The challenges of finding the gene responsible for a rare, autosomal dominant gastric cancer susceptibility syndrome

    JJ Li, S Healey, K Phillips, I Makunin, N Wayte in Hereditary Cancer in Clinical Practice (2012)

  15. Article

    Open Access

    Identification of new breast cancer predisposition genes via whole exome sequencing

    MC Southey, DJ Park, F Lesueur, F Odefrey in Hereditary Cancer in Clinical Practice (2012)

  16. Article

    Open Access

    Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients

    ER Thompson, SE Boyle, J Johnson, GL Ryland in Hereditary Cancer in Clinical Practice (2012)

  17. Article

    Open Access

    The Australian Ovarian Cancer Study

    N Traficante, S Fereday, L Galletta, J Hung in Hereditary Cancer in Clinical Practice (2012)

  18. Article

    Open Access

    Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk

    Somatic mutations in phosphoinositide-3-kinase catalytic subunit alpha (PIK3CA) are frequent in breast tumours and have been associated with oestrogen receptor (ER) expression, human epidermal growth factor recep...

    K N Stevens, M Garcia-Closas, Z Fredericksen, M Kosel in British Journal of Cancer (2011)

  19. No Access

    Article

    Folate and related micronutrients, folate-metabolising genes and risk of ovarian cancer

    Folates are essential for DNA synthesis and methylation, and thus may have a role in carcinogenesis. Limited evidence suggests folate-containing foods might protect against some cancers and may partially mitig...

    P M Webb, T I Ibiebele, M C Hughes, J Beesley in European Journal of Clinical Nutrition (2011)

  20. Article

    Open Access

    Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2

    Single-nucleotide polymorphisms (SNPs) in genes involved in DNA repair are good candidates to be tested as phenotypic modifiers for carriers of mutations in the high-risk susceptibility genes BRCA1 and BRCA2. The...

    A Osorio, R L Milne, R Alonso, G Pita, P Peterlongo, A Teulé in British Journal of Cancer (2011)

previous disabled Page of 2